Kukreja, R C <br/><br/>
Cardiovascular protection with sildenafil following chronic inhibition of nitric oxide synthase.  [electronic resource] 

 -  British journal of pharmacology  Mar 2007 
 - 538-40 p.  digital 
<br/><br/> Publication Type: Comment; Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>0007-1188 
<br/><br/><label>Standard No.: </label>10.1038/sj.bjp.0707132  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>3',5'-Cyclic-GMP Phosphodiesterases--antagonists & inhibitors<br/>Animals<br/>Antihypertensive Agents--pharmacology<br/>Carbolines--pharmacology<br/>Cardiomyopathies--chemically induced<br/>Cardiovascular Agents--pharmacology<br/>Cyclic Nucleotide Phosphodiesterases, Type 5<br/>Disease Models, Animal<br/>Doxorubicin<br/>Endothelium, Vascular--drug effects<br/>Enzyme Inhibitors<br/>Erectile Dysfunction--drug therapy<br/>Heart Failure--drug therapy<br/>Humans<br/>Hypertension--chemically induced<br/>Hypertension, Pulmonary--drug therapy<br/>Imidazoles--pharmacology<br/>Male<br/>Myocardial Infarction--drug therapy<br/>Myocardial Reperfusion Injury--chemically induced<br/>NG-Nitroarginine Methyl Ester<br/>Nitric Oxide--metabolism<br/>Phosphodiesterase Inhibitors--pharmacology<br/>Piperazines--pharmacology<br/>Purines--pharmacology<br/>Sildenafil Citrate<br/>Sulfones--pharmacology<br/>Tadalafil<br/>Triazines--pharmacology<br/>Vardenafil Dihydrochloride<br/>Vasodilator Agents--pharmacology<br/>Ventricular Remodeling--drug effects